Market analysis of Diabetic products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries
  • Hormone replacement therapy
  • Blood glucose monitoring system
  • Smart insulin
  • Timesulin
  • Insulin Powder

Are you interested in

Mail us at

Drop us an email for Program enquiry
diabetes@alliedconferences.org
Sponsors/Exhibiting/Advertising
diabetes@alliedconference.com
General Queries
diabetes@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.
Copyright © 2017-2018 Allied Academies, All Rights Reserved.